首页> 外文会议>SPIE Medical Imaging Conference >Intratumor heterogeneity of DCE-MRI reveals Ki-67 proliferation status in breast cancer
【24h】

Intratumor heterogeneity of DCE-MRI reveals Ki-67 proliferation status in breast cancer

机译:DCE-MRI的肿瘤内异质性显示乳腺癌中Ki-67的增殖状态

获取原文

摘要

Breast cancer is a highly heterogeneous disease both biologically and clinically, and certain pathologic parameters, i.e., Ki67 expression, are useful in predicting the prognosis of patients. The aim of the study is to identify intratumor heterogeneity of breast cancer for predicting Ki-67 proliferation status in estrogen receptor (ER)-positive breast cancer patients. A dataset of 77 patients was collected who underwent dynamic contrast enhancement magnetic resonance imaging (DCE-MRI) examination. Of these patients, 51 were high-K.i-67 expression and 26 were low-Ki-67 expression. We partitioned the breast tumor into subregions using two methods based on the values of time to peak (TTP) and peak enhancement rate (PER). Within each tumor subregion, image features were extracted including statistical and morphological features from DCE-MRI. The classification models were applied on each region separately to assess whether the classifiers based on features extracted from various subregions features could have different performance for prediction. An area under a receiver operating characteristic curve (AUC) was computed using leave-one-out cross-validation (LOOCV) method. The classifier using features related with moderate time to peak achieved best performance with AUC of 0.826 than that based on the other regions. While using multi-classifier fusion method, the AUC value was significantly (P=0.03) increased to 0.858 ±0.032 compare to classifier with AUC of 0.778 using features from the entire tumor. The results demonstrated that features reflect heterogeneity in intratumoral subregions can improve the classifier performance to predict the Ki-67 proliferation status than the classifier using features from entire tumor alone.
机译:乳腺癌在生物学和临床上都是高度异质性疾病,某些病理参数,即Ki67表达,可用于预测患者的预后。该研究的目的是鉴定乳腺癌的肿瘤内异质性,以预测雌激素受体(ER)阳性乳腺癌患者的Ki-67增殖状态。收集了77例接受动态对比增强磁共振成像(DCE-MRI)检查的患者的数据集。在这些患者中,有51位是高K.i-67表达,有26位是低Ki-67表达。我们根据到达峰值时间(TTP)和峰值增强率(PER)的值,使用两种方法将乳腺肿瘤分为多个子区域。在每个肿瘤子区域内,从DCE-MRI中提取图像特征,包括统计和形态特征。将分类模型分别应用于每个区域,以评估基于从各个子区域特征中提取的特征的分类器是否可能具有不同的预测性能。使用留一法交叉验证(LOOCV)方法计算接收器工作特性曲线(AUC)下的面积。与使用其他区域的分类器相比,使用具有适度峰化时间相关特征的分类器以0.826的AUC可获得最佳性能。使用多分类器融合方法时,与使用整个肿瘤特征的AUC为0.778的分类器相比,AUC值显着提高(P = 0.03)至0.858±0.032。结果表明,与仅使用来自整个肿瘤的特征的分类器相比,特征反映了肿瘤内子区域的异质性可以改善分类器的性能,从而预测Ki-67增殖状态。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号